Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/3/2019
SIETES contiene 92692 citas

 
 
 1 a 20 de 559 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bafeta A, Koh M, Riveros C, Ravaud P. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann Intern Med 2018;169:240-7. [Ref.ID 102815]
2. Cita con resumen
3.Enlace a cita original
Pfeffer MA, McMurray JJV. Lessons in uncertainty and humility — Clinical trials involving hypertension. N Engl J Med 2016;375:1756-66. [Ref.ID 100966]
5. Cita con resumen
Moore N. Lessons from the fatal French study BIA-10-2474. BMJ 2016;353:i2727. [Ref.ID 100424]
6. Cita con resumen
Casassus B. New report on drug trial disaster in France. Lancet 2016;387:2187. [Ref.ID 100334]
7.Enlace a cita original
Kim H-S, Lim Y, Oh M, Ghim J-I, Kim E-Y, Kim DH, Shin J-G. The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes. Br J Clin Pharmacol 2016;81:301-12. [Ref.ID 100147]
8.Tiene citas relacionadas Cita con resumen
Gotzsche PC. Author’s reply to Dubicka and colleagues and Stone. BMJ 2016;352:i915. [Ref.ID 100054]
9. Cita con resumen
Casassus B. France releases interim report on drug trial disaster. Lancet 2016;387:634-5. [Ref.ID 100049]
10. Cita con resumen
Casassus B. France investigates drug trial disaster. Lancet 2016;387:326. [Ref.ID 99978]
11. Cita con resumen
Anónimo. One dead, five hospitalized in French clinical trial. DIA Daily 2016:19 de enero. [Ref.ID 99970]
12. Cita con resumen
Glund S, Stangier J, Schmohl M, Gansser D, Norris S, Van Ryn J, Lang B, Ramael S, Moschetti V, Gruenenfelder F, Reilly P, Kreuzer J. Articles Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Lancet 2015;386:680-90. [Ref.ID 99494]
13. Cita con resumen
Anónimo. Gluconorm (repaglinide) - New contraindication for concomitant use with clopidogrel . Healthy Canadians 2015:31 de julio. [Ref.ID 99386]
14. Cita con resumen
Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]
15.Tiene citas relacionadas Cita con resumen
Kimmelman J. The secret realm of phase I trials in healthy volunteers. BMJ 2015;350:h3444. [Ref.ID 99219]
16.Tiene citas relacionadas Cita con resumen
Emanuel EJ, Bedarina G, Macci K, Gabler NB, Rid A, Wendler D. Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies. BMJ 2015;350:h3271. [Ref.ID 99218]
17. Cita con resumen
Dyer O. Experimental drug that injured UK volunteers resumes in human trials. BMJ 2015;350:h1831. [Ref.ID 98941]
19. Cita con resumen
Anónimo. Joint pain pauses Merck Ebola vaccine’s phase I. DIA Daily 2014:12 de diciembre. [Ref.ID 98386]
20. Cita con resumen
Anónimo. Swiss vaccine to treat Ebola approved for human trials. DIA Daily 2014:29 de octubre. [Ref.ID 98238]
Seleccionar todas
 
 1 a 20 de 559 siguiente >>